FIIs trim stake in Biocon in Q2FY15

13 Oct 2014 Evaluate

Foreign institutional investors (FIIs) have reduced their stake in Biocon by 98 basis points to 13.05 percent at the end of September 2014 quarter from 14.03 percent as on June 30, 2014. On the flip side, domestic institutional investors (DIIs) have raised their shareholding in the bank by 92 basis points to 6.95 percent in Q2FY15 from 6.03 percent as on June 30, 2014.

Biocon is India’s largest and Asia's leading biotechnology company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

384.65 -5.90 (-1.51%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×